T Laughren
Overview
Explore the profile of T Laughren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Menon-Andersen D, Yu B, Madabushi R, Bhattaram V, Hao W, Uppoor R, et al.
Clin Pharmacol Ther
. 2011 Jul;
90(3):471-4.
PMID: 21796114
No abstract available.
2.
3.
Laughren T
Clin Ther
. 1999 Jan;
20 Suppl C:C12-9.
PMID: 9915085
This paper discusses the premarketing safety database that the US Food and Drug Administration receives from drug manufacturers. It reviews the kind of data we usually receive, what we do...
4.
Faraone S, Curran J, Laughren T, Faltus F, Johnston R, Brown W
Psychiatry Res
. 1986 Dec;
19(4):311-22.
PMID: 2880360
Serum neuroleptic levels, prolactin levels, and clinical state were assessed for 1 year in 29 schizophrenic outpatients whose clinically determined neuroleptic dose had been reduced by 50%. Fifty-five percent of...
5.
Brown W, Laughren T
Psychopharmacol Bull
. 1983 Jan;
19(1):76-8.
PMID: 6131471
No abstract available.
6.
Brown W, Laughren T, Chisholm E, Williams B
Arch Gen Psychiatry
. 1982 Sep;
39(9):998-1000.
PMID: 6126172
Relapse occurs in a substantial proportion of schizophrenic patients treated with neuroleptics. The determinants of relapse have been elusive. In our study, low serum neuroleptic levels identified patients who had...
7.
8.
Gustafson D, Greist J, Stauss F, ERDMAN H, Laughren T
Comput Biomed Res
. 1977 Apr;
10(2):83-9.
PMID: 322942
No abstract available.